11 results
COVID-19 Diagnosis and Management Summary

 • Clinical Presentation
 • Testing
 • Imaging
 • Laboratory Findings
 •
COVID-19 Diagnosis ... and Management ... #COVID19 #diagnosis ... #management #treatment ... #summary #sarscov2
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications due to #COVID19 ... Medications #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... sedative #analgesia #pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
causing COVID-19 ... ivermectin… #COVID19 ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
COVID-19 • Virus ... emergency 2020-3-12 Diagnosis ... #Cheatsheet #Diagnosis ... #Management #Summary ... #SARSCoV2 #Coronavirus
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... or been newly diagnosed ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
COVID19 - Community Mitigation Strategy
In the 1st (steepest) curve, virus reproduces quickly in a short period
COVID19 - Community ... steepest) curve, virus ... receive better treatment ... SocialDistancing #Management ... #Policy #SARSCoV2
Possible Approach to Immunosuppression in Severe COVID-19

The diagnosis and treatment of cytokine storm remains unknown and
-19 The diagnosis ... and treatment of ... reasonable, but treatment ... #management #schema ... criticalcare #algorithm #SARSCOV2
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
like illnesses, COVID ... 19 - Zika virus ... Guillain-Barre Diagnosis ... Barre #Syndrome #diagnosis ... #management #treatment
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Herpes Simplex Virus ... • Continue treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... health-care provider diagnosis ... #Zoster #VZV #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology